- Home
- SGLY vs IMNN Comparison
SGLY vs IMNN Comparison
Compare SGLY & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGLY
- IMNN
- Stock Information
- Founded
- SGLY 2001
- IMNN 1982
- Country
- SGLY United States
- IMNN United States
- Employees
- SGLY N/A
- IMNN N/A
- Industry
- SGLY
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- SGLY
- IMNN Health Care
- Exchange
- SGLY Nasdaq
- IMNN Nasdaq
- Market Cap
- SGLY 15.9M
- IMNN 15.1M
- IPO Year
- SGLY 2008
- IMNN 1985
- Fundamental
- Price
- SGLY $1.71
- IMNN $1.02
- Analyst Decision
- SGLY
- IMNN Strong Buy
- Analyst Count
- SGLY 0
- IMNN 2
- Target Price
- SGLY N/A
- IMNN $21.50
- AVG Volume (30 Days)
- SGLY 190.3K
- IMNN 245.4K
- Earning Date
- SGLY 11-11-2024
- IMNN 11-12-2024
- Dividend Yield
- SGLY N/A
- IMNN N/A
- EPS Growth
- SGLY N/A
- IMNN N/A
- EPS
- SGLY N/A
- IMNN N/A
- Revenue
- SGLY $3,370,424.00
- IMNN N/A
- Revenue This Year
- SGLY N/A
- IMNN N/A
- Revenue Next Year
- SGLY N/A
- IMNN N/A
- P/E Ratio
- SGLY N/A
- IMNN N/A
- Revenue Growth
- SGLY N/A
- IMNN N/A
- 52 Week Low
- SGLY $1.27
- IMNN $0.48
- 52 Week High
- SGLY $8.00
- IMNN $3.65
- Technical
- Relative Strength Index (RSI)
- SGLY 42.42
- IMNN 45.16
- Support Level
- SGLY $1.27
- IMNN $0.99
- Resistance Level
- SGLY $1.79
- IMNN $1.08
- Average True Range (ATR)
- SGLY 0.28
- IMNN 0.07
- MACD
- SGLY 0.09
- IMNN 0.00
- Stochastic Oscillator
- SGLY 37.29
- IMNN 26.92
About SGLY Singularity Future Technology Ltd.
Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.
About IMNN Imunon Inc.
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.